Items where authors include "Knebelmann, B."

Article

Zagorec, N., Calamel, A., Delaporte, M. et al. (24 more authors) (2024) Clinical spectrum and prognosis of atypical autosomal dominant polycystic kidney disease caused by monoallelic pathogenic variants of IFT140. American Journal of Kidney Diseases. ISSN 0272-6386

Bais, T., Meijer, E. orcid.org/0000-0001-7875-1793, Kramers, B.J. et al. (15 more authors) (2024) HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trial. Trials, 25 (1). 120. ISSN 1745-6215

Gansevoort, R.T., Hariri, A., Minini, P. et al. (11 more authors) (2023) Venglustat, a novel glucosylceramide synthase inhibitor, in patients at risk of rapidly progressing ADPKD: primary results of a double-blind, placebo-controlled, phase 2/3 randomized clinical trial. American Journal of Kidney Diseases, 81 (5). 517-527.e1. ISSN 0272-6386

Perrone, R.D., Hariri, A., Minini, P. et al. (10 more authors) (2022) The STAGED-PKD 2-stage adaptive study with a patient enrichment strategy and treatment effect modeling for improved study design efficiency in patients with ADPKD. Kidney Medicine, 4 (10). 100538. ISSN 2590-0595

Gansevoort, R.T., Arici, M., Benzing, T. et al. (18 more authors) (2016) Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology Dialysis Transplantation, 31 (3). pp. 337-348. ISSN 0931-0509